Investigational drug · Phase 2
RXC007
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for IPF, Fibrosis.
Phase 2Last checked: Nov 19, 2026Latest source record: Aug 23, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "RXC007"
First trial start
2022
Sep 8, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "RXC007", any sponsor or status.
Conditions studied
As listed on its trial records.
- IPF
- Fibrosis
Largest trials
Live from ClinicalTrials.gov: studies naming "RXC007" as an intervention, largest first.
Redx Pharma LtdIndustry
NCT04931147 · 90 participants · Start May 13, 2021 · Primary completion Mar 8, 2023
Drug: RXC007; RXC007 Matching Placebo · For: Fibrosis; Inflammation; Idiopathic Pulmonary Fibrosis and 3 more
Sites: Merthyr Tydfil, United Kingdom
- Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary FibrosisActive, not recruiting
Redx Pharma LtdIndustry
NCT05570058 · 48 participants · Start Sep 8, 2022 · Primary completion Jun 25, 2024
Drug: RXC007; Placebo · For: IPF; Fibrosis
Sites: Vienna, Austria; Leuven, Belgium; Liège, Belgium · 31 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for IPF
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.